|
1
|
Matrix metalloproteinases.
|
Br J Surg
|
1997
|
2.25
|
|
2
|
Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence.
|
Gut
|
2000
|
1.73
|
|
3
|
Expression of gastrin in developing gastric adenocarcinoma.
|
Br J Surg
|
2001
|
1.65
|
|
4
|
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
|
Br J Cancer
|
1998
|
1.53
|
|
5
|
Malignant ascites.
|
Br J Surg
|
1996
|
1.26
|
|
6
|
Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I.
|
Br J Cancer
|
1991
|
1.09
|
|
7
|
Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion.
|
Eur J Surg Oncol
|
2005
|
1.08
|
|
8
|
De-regulation of the sonic hedgehog pathway in the InsGas mouse model of gastric carcinogenesis.
|
Br J Cancer
|
2007
|
1.08
|
|
9
|
Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines.
|
Gut
|
1998
|
1.05
|
|
10
|
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer.
|
Gut
|
2003
|
1.01
|
|
11
|
Hormonal control of gastric and colorectal cancer in man.
|
Gut
|
1989
|
1.00
|
|
12
|
Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
|
Br J Cancer
|
2001
|
1.00
|
|
13
|
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
|
Gut
|
2003
|
0.97
|
|
14
|
G17DT: an antigastrin immunogen for the treatment of gastrointestinal malignancy.
|
Expert Opin Biol Ther
|
2007
|
0.96
|
|
15
|
Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites.
|
Eur J Surg Oncol
|
1997
|
0.92
|
|
16
|
Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer.
|
Clin Cancer Res
|
2000
|
0.91
|
|
17
|
A hepatic invasive human colorectal xenograft model.
|
Eur J Cancer
|
1993
|
0.90
|
|
18
|
Review article: gastrin and colorectal cancer.
|
Aliment Pharmacol Ther
|
2000
|
0.88
|
|
19
|
Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer.
|
Br J Cancer
|
2000
|
0.88
|
|
20
|
A phase II study of G17DT in gastric carcinoma.
|
Eur J Surg Oncol
|
2004
|
0.86
|
|
21
|
Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth.
|
Eur J Surg Oncol
|
2007
|
0.86
|
|
22
|
Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts.
|
Br J Cancer
|
1999
|
0.85
|
|
23
|
Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells.
|
Br J Cancer
|
2007
|
0.84
|
|
24
|
An open multicentre study of the efficacy and safety of a single dose of fluconazole 150 mg in the treatment of vaginal candidiasis in general practice.
|
Br J Clin Pract
|
1990
|
0.83
|
|
25
|
Gastric carcinoid expresses the gastrin autocrine pathway.
|
Br J Surg
|
1998
|
0.83
|
|
26
|
Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
|
Eur J Surg Oncol
|
2005
|
0.83
|
|
27
|
Oestrogen and progesterone receptors in gastrointestinal cancer cell lines.
|
Eur J Cancer
|
1996
|
0.82
|
|
28
|
Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models.
|
Regul Pept
|
2007
|
0.82
|
|
29
|
PTHrP increases transcriptional activity of the integrin subunit alpha5.
|
Br J Cancer
|
2007
|
0.80
|
|
30
|
Antibodies raised against the extracellular tail of the CCKB/gastrin receptor inhibit gastrin-stimulated signalling.
|
Regul Pept
|
2001
|
0.79
|
|
31
|
The role of gastrin in colorectal carcinogenesis.
|
Surgeon
|
2004
|
0.78
|
|
32
|
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
|
Eur J Cancer
|
2002
|
0.78
|
|
33
|
Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy.
|
Regul Pept
|
1999
|
0.78
|
|
34
|
Rubratoxin B hepatotoxicity: an electron microscopic study.
|
Exp Mol Pathol
|
1981
|
0.77
|
|
35
|
A gastrin transcript expressed in gastrointestinal cancer cells contains an internal ribosome entry site.
|
Br J Cancer
|
2008
|
0.77
|
|
36
|
A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
|
Respir Med
|
1999
|
0.76
|
|
37
|
The effect of long acting somatostatin analogue SMS 201.995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancer.
|
Br J Cancer
|
1991
|
0.76
|
|
38
|
Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer.
|
Int J Cancer
|
1995
|
0.76
|
|
39
|
A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C170HM2.
|
Cancer Res
|
1999
|
0.76
|
|
40
|
Heritability of Variations in Oil Content of Individual Corn Kernels.
|
Science
|
1963
|
0.76
|
|
41
|
The effect of onapristone, a progesterone antagonist, on the growth of human gastrointestinal cancer xenografts.
|
Eur J Cancer
|
1997
|
0.76
|
|
42
|
Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts.
|
Int J Cancer
|
2001
|
0.76
|
|
43
|
THE RELATIONSHIP OF RIBOFLAVIN AND ASCORBIC ACID TO CARBOHYDRATE AND NITROGEN FRACTIONS IN IMMATURE OAT PLANTS AS INFLUENCED BY MINERAL DEFICIENCIES.
|
Plant Physiol
|
1949
|
0.75
|
|
44
|
Correspondence re: Weinberg et al., Cholecystokinin and gastrin levels are not elevated in pancreatic carcinoma. Cancer Epidemiol. Biomark. Prev., 10: 721-722, 2001.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.75
|
|
45
|
Gastrin in pancreatic tumors transfected with CCK-B receptors.
|
Gastroenterology
|
1998
|
0.75
|
|
46
|
Non-cytotoxic control of colorectal cancer.
|
J R Coll Surg Edinb
|
1998
|
0.75
|
|
47
|
Binding of rubratoxin B to mouse hepatic microsomes and in vitro effects of the mycotoxin on polysome binding to microsomal membranes as measured by the activity of an enzyme catalyzing disulphide interchange.
|
Toxicon
|
1981
|
0.75
|
|
48
|
A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
|
Respir Med
|
1999
|
0.75
|
|
49
|
Analysis for trichothecenes in samples from Southeast Asia associated with "Yellow Rain".
|
Fundam Appl Toxicol
|
1984
|
0.75
|
|
50
|
Epikeratophakia following previous refractive keratoplasty surgery: two case reports.
|
J Cataract Refract Surg
|
1986
|
0.75
|
|
51
|
Gastrimmune-induced antigastrin-17 antibodies inhibit acid secretion in a rat fistula model.
|
Aliment Pharmacol Ther
|
2001
|
0.75
|
|
52
|
Evaluation of possible sites of action of rubratoxin B-induced polyribosomal disaggregation in mouse liver.
|
J Toxicol Environ Health
|
1977
|
0.75
|
|
53
|
The effect of jaundice on the generation of anti-gastrin antibodies in G17DT immunized patients with advanced pancreatic cancer.
|
Eur J Surg Oncol
|
2005
|
0.75
|
|
54
|
Effects of alterations of metabolism on rubratoxin B toxicity in vivo and in the isolated rat parenchymal cell.
|
Toxicol Appl Pharmacol
|
1982
|
0.75
|